Evaluation of Vaccination Reminder/Recall Systems for Adolescent Patients

NCT00715234 | Completed

• 2 other identifiers: 07-0763U01IP000129
• Study Type: interventional
• Target: 4,807
• Locations: 0 countries
• Sites: N/A

Brief Summary

A study team with extensive experience in immunization delivery research will evaluate the effectiveness of vaccination reminder/recall systems for adolescent patients in five types of clinical settings including: urban pediatric, urban family medicine and rural family medicine practices, public pediatric clinics, and school-based health centers. Randomized controlled trials of reminder/recall for adolescents will be conducted at each type of site, with randomization at the level of the patient.

Conditions

Human Papilloma Virus (HPV); Tetanus-diphtheria-acellular Pertussis (Tdap); Meningococcal Infection; Varicella

Keywords

adolescent reminder/recall; adolescent vaccines; Tdap; Meningococcal; HPV; Reminder cards; Recall messages; vaccine; conjugate

Outcome Measures

Primary Outcomes (2)

• 1) the percentage receiving any vaccine after the baseline time point

  6 months after intervention

• The percentage of adolescents becoming up-to-date on all needed immunizations

  6 months post intervention

Study Arms (2)

Reminder/recall notices for vaccines

EXPERIMENTAL

This group will receive up to 4 recall messages (both letters and computer-generated phone messages) reminding them to get their vaccines. There are 4 separate study groups: 1) private pediatric patients 2) public pediatric patients 3) school-based health center patients and 4) family medicine patients.

Other: Reminder/recall notices for vaccines

Usual Care

NO INTERVENTION

This group will receive usual care. There are 4 separate study groups: 1) private pediatric patients 2) public pediatric patients 3) school-based health center patients and 4) family medicine patients.

Interventions

Reminder/recall notices for vaccines OTHER

1. Receive a generic letter reminding them to make an appointment to get vaccines. 2. Receive a computer-generated telephone message at 1 week post initial letter. 3. Receive a computer-generated telephone message at 2 months post initial letter. 4. Receive a letter at 3 months post initial letter.

Reminder/recall notices for vaccines

Eligibility Criteria

• Age: 11 Years - 18 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64)

You may qualify if:

• children ages 11-18
• seen in practice in last 2 years
• not up-to-date on any or all shots (Tdap, HPV, meningococcal)
• parents agree to participate in Colorado Immunization and Information System registry

You may not qualify if:

• up-to-date on all vaccines
• under age 11 over age 18
• patients who have moved or gone elsewhere at each practice setting

Sponsors & Collaborators

• University of Colorado, Denver: lead
• Centers for Disease Control and Prevention: collaborator

Related Publications (7)

• Ziv A, Boulet JR, Slap GB. Utilization of physician offices by adolescents in the United States. Pediatrics. 1999 Jul;104(1 Pt 1):35-42. doi: 10.1542/peds.104.1.35.

  PMID: 10390257 BACKGROUND

• Schaffer SJ, Humiston SG, Shone LP, Averhoff FM, Szilagyi PG. Adolescent immunization practices: a national survey of US physicians. Arch Pediatr Adolesc Med. 2001 May;155(5):566-71. doi: 10.1001/archpedi.155.5.566.

  PMID: 11343499 BACKGROUND

• Briss PA, Rodewald LE, Hinman AR, Shefer AM, Strikas RA, Bernier RR, Carande-Kulis VG, Yusuf HR, Ndiaye SM, Williams SM. Reviews of evidence regarding interventions to improve vaccination coverage in children, adolescents, and adults. The Task Force on Community Preventive Services. Am J Prev Med. 2000 Jan;18(1 Suppl):97-140. doi: 10.1016/s0749-3797(99)00118-x.

  PMID: 10806982 BACKGROUND

• Humiston SG, Rosenthal SL. Challenges to vaccinating adolescents: vaccine implementation issues. Pediatr Infect Dis J. 2005 Jun;24(6 Suppl):S134-40. doi: 10.1097/01.inf.0000166161.12087.94.

  PMID: 15931141 BACKGROUND

• Szilagyi PG, Bordley C, Vann JC, Chelminski A, Kraus RM, Margolis PA, Rodewald LE. Effect of patient reminder/recall interventions on immunization rates: A review. JAMA. 2000 Oct 11;284(14):1820-7. doi: 10.1001/jama.284.14.1820.

  PMID: 11025835 BACKGROUND

• Kempe A, Lowery NE, Pearson KA, Renfrew BL, Jones JS, Steiner JF, Berman S. Immunization recall: effectiveness and barriers to success in an urban teaching clinic. J Pediatr. 2001 Nov;139(5):630-5. doi: 10.1067/mpd.2001.117069.

  PMID: 11713438 BACKGROUND

• Suh CA, Saville A, Daley MF, Glazner JE, Barrow J, Stokley S, Dong F, Beaty B, Dickinson LM, Kempe A. Effectiveness and net cost of reminder/recall for adolescent immunizations. Pediatrics. 2012 Jun;129(6):e1437-45. doi: 10.1542/peds.2011-1714. Epub 2012 May 7.

  PMID: 22566415 DERIVED

MeSH Terms

Conditions

Meningococcal Infections; Chickenpox

Interventions

Vaccines

Condition Hierarchy (Ancestors)

Neisseriaceae Infections; Gram-Negative Bacterial Infections; Bacterial Infections; Bacterial Infections and Mycoses; Infections; Varicella Zoster Virus Infection; Herpesviridae Infections; DNA Virus Infections; Virus Diseases

Intervention Hierarchy (Ancestors)

Biological Products; Complex Mixtures

Study Officials

• Allison Kempe, MD, MPH

  University of Colorado, Denver

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Purpose: PREVENTION
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: July 10, 2008
• First Posted: July 15, 2008
• Study Start: October 1, 2007
• Primary Completion: December 1, 2009
• Study Completion: September 1, 2010
• Last Updated: June 25, 2013

Record last verified: 2013-06